HLA-A*02:01 gp100 peptide complex Tetramer

//HLA-A*02:01 gp100 peptide complex Tetramer

HLA-A*02:01 gp100 peptide complex Tetramer


SKU: MHCGP100T Category:

accession GP100

Source DNA sequence encoding the Human (HLA-A*02:01) AA25-305 [accession# P04439] and the B2M protein AA2-119 [accession# P61769], fused to the GP100 (PMEL) peptide YLEPGPVTA .This complex includes a C terminal polyHis AVI tag and was expressed in HEK cells, The tetramer conformation was achieved through biotinylation of the monomer and then covalently binding the monomers via an avidin biotin reaction.
Molecular weight Recombinant HLA-A/GP100 Tetramer has a calculated mass of approximately 50kDa. Due to glycosylation migrates as an approximately 60 kDa protein under reducing conditions in SDS-PAGE.
Purity purity was determined to be >95% by nonreducing PAGE and HPLC (see below methods)
Endotoxin Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).
Presentation Recombinant HLA-A*02:01 GP100 Tetramer was lyophilized from 0.2 µm filtered PBS solution pH7.4
Reconstitution A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Storage The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.
Usage This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.


HLA-A*02:01 GP100 complex Tetramer HPLC

  • The purity of GP100 (HLA-A*02:01)complex Tetramer was greater than 95% as determined by SEC-HPLC.

HLA-A*02:01 GP100 peptide complex Tetramer PAGE

  • 1ug loaded Tris-Bis PAGE under reducing condition. The purity is greater than 95%.

HLA-A*02:01 GP100 complex peptide Tetramercomplex ELISA

  • Dose response curve for Anti-HLA-A*02:01 GP100 Antibody